joint product development agreementJoint Product Development Agreement • July 7th, 2016 • Cellect Biomed Ltd. • Biological products, (no disgnostic substances) • England and Wales
THIS JOINT PRODUCT DEVELOPMENT AGREEMENT (“Agreement”), effective as of the 17th day of June, 2015 (“Effective Date”), is made and entered into by and between CELLECT BIOMED LTD., an Israeli corporation with its principal office located at 10 Hataas Street, Kfar Saba, Israel (“Cellect”), and ENTEGRIS, INC., a Delaware corporation with its principal office located at 129 Concord Road Billerica, MA 01821 (“Entegris”). Each of Cellect and Entegris are sometimes hereinafter referred to as a “Party” and collectively as the “Parties”.
Employment Agreement Entered into on April 30, 2013 By and BetweenEmployment Agreement • July 7th, 2016 • Cellect Biomed Ltd. • Biological products, (no disgnostic substances)
Whereas the Employee is interested in working in the Company and the Company is interested to employ the Employee as CEO and the Company's president as specified in this agreement and all according to the manner, conditions and consideration set forth in this agreement as follows;
Chairman of the Board Agreement Entered into on April 30, 2013 By and BetweenChairman of the Board Agreement • July 7th, 2016 • Cellect Biomed Ltd. • Biological products, (no disgnostic substances)
And whereas The Company’s shareholders are about to perform a share exchange transaction under section 103t with a "shell company" (the public company) such that after the exchange the Company shall be a subsidiary wholly owned by the public company;
Consulting Agreement Entered into on April 30, 2013 By and BetweenConsulting Agreement • July 7th, 2016 • Cellect Biomed Ltd. • Biological products, (no disgnostic substances)
Whereas The Company addressed the Consultant for receiving its services as the Company's chief scientist (the consulting services or the services);
